CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $694,225 | -17.1% | 23,565 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $837,588 | -7.1% | 25,677 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $901,960 | -21.6% | 25,631 | +2.1% | 0.00% | -50.0% |
| Q4 2022 | $1,150,497 | -12.4% | 25,109 | -7.4% | 0.00% | 0.0% |
| Q3 2022 | $1,314,000 | +22.7% | 27,115 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $1,071,000 | +2.7% | 27,251 | -3.8% | 0.00% | +100.0% |
| Q1 2022 | $1,043,000 | -19.6% | 28,317 | -0.5% | 0.00% | -50.0% |
| Q4 2021 | $1,297,000 | +20.0% | 28,469 | -5.9% | 0.00% | 0.0% |
| Q3 2021 | $1,081,000 | +136.0% | 30,248 | +30.8% | 0.00% | +100.0% |
| Q2 2021 | $458,000 | -14.9% | 23,132 | +0.0% | 0.00% | 0.0% |
| Q1 2021 | $538,000 | +78.7% | 23,121 | +59.9% | 0.00% | 0.0% |
| Q4 2020 | $301,000 | +15.8% | 14,460 | +20.2% | 0.00% | 0.0% |
| Q3 2020 | $260,000 | -13.6% | 12,027 | -5.8% | 0.00% | 0.0% |
| Q2 2020 | $301,000 | – | 12,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |